These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

393 related items for PubMed ID: 34737223

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Real-life prevalence of progressive fibrosing interstitial lung diseases.
    Gagliardi M, Berg DV, Heylen CE, Koenig S, Hoton D, Tamirou F, Pieters T, Ghaye B, Froidure A.
    Sci Rep; 2021 Dec 14; 11(1):23988. PubMed ID: 34907290
    [Abstract] [Full Text] [Related]

  • 6. Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registry.
    Hambly N, Farooqi MM, Dvorkin-Gheva A, Donohoe K, Garlick K, Scallan C, Chong SG, MacIsaac S, Assayag D, Johannson KA, Fell CD, Marcoux V, Manganas H, Morisset J, Comes A, Fisher JH, Shapera S, Gershon AS, To T, Wong AW, Sadatsafavi M, Wilcox PG, Halayko AJ, Khalil N, Cox G, Richeldi L, Ryerson CJ, Kolb M.
    Eur Respir J; 2022 Oct 14; 60(4):. PubMed ID: 35273032
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Interstitial Lung Disease: A Review.
    Maher TM.
    JAMA; 2024 May 21; 331(19):1655-1665. PubMed ID: 38648021
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial.
    Maher TM, Corte TJ, Fischer A, Kreuter M, Lederer DJ, Molina-Molina M, Axmann J, Kirchgaessler KU, Samara K, Gilberg F, Cottin V.
    Lancet Respir Med; 2020 Feb 21; 8(2):147-157. PubMed ID: 31578169
    [Abstract] [Full Text] [Related]

  • 20. Progressive fibrosing interstitial lung disease: prevalence and clinical outcome.
    Kwon BS, Choe J, Chae EJ, Hwang HS, Kim YG, Song JW.
    Respir Res; 2021 Oct 31; 22(1):282. PubMed ID: 34719401
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.